EYEG insider filings

EYEGATE PHARMACEUTICALS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-11-03. Screen EYEG transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for EYEG between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — EYEGATE PHARMACEUTICALS INC

FiledFormInsiderReported transactionsSource
2021-11-034FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 250 @ $1.98EDGAR
2021-11-034Mann Brenda — VP of Research & DevelopmentTax withholding (F): 62 @ $1.98EDGAR
2021-11-034Romano Sarah — Chief Financial OfficerTax withholding (F): 83 @ $1.98EDGAR
2021-10-054Romano Sarah — Chief Financial OfficerTax withholding (F): 83 @ $2.01EDGAR
2021-10-054Mann Brenda — VP of Research & DevelopmentTax withholding (F): 62 @ $2.01EDGAR
2021-10-054FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 249 @ $2.01EDGAR
2021-09-034FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 253 @ $1.81EDGAR
2021-09-034Romano Sarah — Chief Financial OfficerTax withholding (F): 84 @ $1.81EDGAR
2021-09-034Mann Brenda — VP of Research & DevelopmentTax withholding (F): 61 @ $1.81EDGAR
2021-08-044FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 261 @ $2.40EDGAR
2021-08-044MANZO MICHAEL P. — VP of EngineeringTax withholding (F): 65 @ $2.40EDGAR
2021-08-044Mann Brenda — VP of Research & DevelopmentTax withholding (F): 63 @ $2.40EDGAR
2021-08-044Romano Sarah — Chief Financial OfficerTax withholding (F): 87 @ $2.40EDGAR
2021-08-034ARMISTICE CAPITAL, LLC — 10% owner
Armistice Capital Master Fund Ltd. — 10% owner
Boyd Steven — 10% owner
Sale (S): 68,188 @ $2.69 · Sale (S): 192,775 @ $2.40EDGAR
2021-08-024Strem Brian M. — President and CEO, DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-07-294ARMISTICE CAPITAL, LLC — Director, 10% owner
Armistice Capital Master Fund Ltd. — Director, 10% owner
Boyd Steven — Director, 10% owner
Conversion (C): 852,500 @ $4.80 · Sale (S): 73,101 @ $7.06 · Sale (S): 461,797 @ $6.45 · Sale (S): 729,114 @ $5.44 · Sale (S): 532,069 @ $4.59 · Sale (S): 581,614 @ $3.80 · +3 moreEDGAR
2021-07-064Romano Sarah — Chief Financial OfficerTax withholding (F): 180 @ $3.70EDGAR
2021-07-064MANZO MICHAEL P. — VP of EngineeringTax withholding (F): 160 @ $3.70EDGAR
2021-07-064Mann Brenda — VP of Research & DevelopmentTax withholding (F): 154 @ $3.70EDGAR
2021-07-064FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 877 @ $3.70EDGAR
2021-06-074FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 878 @ $4.19EDGAR
2021-06-074Romano Sarah — Chief Financial OfficerTax withholding (F): 180 @ $4.19EDGAR
2021-06-074MANZO MICHAEL P. — VP of EngineeringTax withholding (F): 155 @ $4.19EDGAR
2021-06-074Mann Brenda — VP of Research & DevelopmentTax withholding (F): 155 @ $4.19EDGAR
2021-05-054FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 889 @ $4.13EDGAR
2021-05-054Romano Sarah — Chief Financial OfficerTax withholding (F): 177 @ $4.13EDGAR
2021-05-054MANZO MICHAEL P. — VP of EngineeringTax withholding (F): 158 @ $4.13EDGAR
2021-05-054Mann Brenda — VP of Research & DevelopmentTax withholding (F): 191 @ $4.13EDGAR
2021-04-214Gayron Kenneth L — DirectorGrant/award (A): 4,000 (derivative) @ $0EDGAR
2021-04-214Shapiro Aron — DirectorGrant/award (A): 4,000 (derivative) @ $0EDGAR
2021-04-094FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 899 @ $4.94EDGAR
2021-04-094Romano Sarah — Chief Financial OfficerTax withholding (F): 180 @ $4.94EDGAR
2021-04-094MANZO MICHAEL P. — VP of EngineeringTax withholding (F): 194 @ $4.94EDGAR
2021-04-094Mann Brenda — VP of Research & DevelopmentTax withholding (F): 192 @ $4.94EDGAR
2021-03-054FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 898 @ $5.46EDGAR
2021-03-054Romano Sarah — Chief Financial OfficerTax withholding (F): 218 @ $5.46EDGAR
2021-03-054MANZO MICHAEL P. — VP of EngineeringTax withholding (F): 192 @ $5.46EDGAR
2021-03-054Mann Brenda — VP of Research & DevelopmentTax withholding (F): 192 @ $5.46EDGAR
2021-02-034MANZO MICHAEL P. — VP of EngineeringTax withholding (F): 990 @ $6.34 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-02-034Mann Brenda — VP of Research & DevelopmentTax withholding (F): 988 @ $6.34 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-02-034FROM STEPHEN — Executive Chairman, DirectorTax withholding (F): 3,542 @ $6.34 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-02-034Romano Sarah — Chief Financial OfficerTax withholding (F): 1,282 @ $6.34 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-02-034HANCOCK THOMAS — DirectorGrant/award (A): 3,333 (derivative) @ $0EDGAR
2021-02-034MALFROY-CAMINE BERNARD — DirectorGrant/award (A): 3,333 (derivative) @ $0EDGAR
2021-02-034GOLDBERG MORTON — DirectorGrant/award (A): 3,333 (derivative) @ $0EDGAR
2021-02-034Obermayr Franz — Acting CEOGrant/award (A): 30,000 (derivative) @ $0EDGAR
2021-02-034TYLE PRAVEEN — DirectorGrant/award (A): 3,333 (derivative) @ $0EDGAR
2021-02-034CHANEY PAUL G — DirectorGrant/award (A): 3,333 (derivative) @ $0EDGAR
2021-01-084ARMISTICE CAPITAL, LLC — Director, 10% owner
Armistice Capital Master Fund Ltd. — Director, 10% owner
Boyd Steven — Director, 10% owner
Purchase (P): 1,531,101 @ $5.22 · Purchase (P): 0 @ $0 · Purchase (P): 1,531,101 (derivative) · Purchase (P): 0 (derivative)EDGAR
2021-01-054Mann Brenda — VP of Research & DevelopmentTax withholding (F): 115 @ $4.85EDGAR

Recent 8-K events — EYEGATE PHARMACEUTICALS INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-298-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-088-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-198-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-088-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-078-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=EYEG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs